ArticleBMC cancer2024

Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy response.

Shengshan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.